Literature DB >> 21376360

Mapping regions of Epstein-Barr virus (EBV) glycoprotein B (gB) important for fusion function with gH/gL.

Aileen E Plate1, Jessica J Reimer, Theodore S Jardetzky, Richard Longnecker.   

Abstract

Glycoproteins gB and gH/gL are required for entry of Epstein-Barr virus (EBV) into cells, but the role of each glycoprotein and how they function together to mediate fusion is unclear. Analysis of the functional homology of gB from the closely related primate gammaherpesvirus, rhesus lymphocryptovirus (Rh-LCV), showed that EBV gB could not complement Rh gB due to a species-specific dependence between gB and gL. To map domains of gB required for this interaction, we constructed a panel of EBV/Rh gB chimeric proteins. Analysis showed that insertion of Rh gB from residues 456 to 807 restored fusion function of EBV gB with Rh gH/gL, suggesting this region of gB is important for interaction with gH/gL. Split YFP bimolecular complementation (BiFC) provided evidence of an interaction between EBV gB and gH/gL. Together, our results suggest the importance of a gB-gH/gL interaction in EBV-mediated fusion with B cells requiring the region of EBV gB from 456 to 807.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21376360      PMCID： PMC3075949          DOI： 10.1016/j.virol.2010.12.006

Source DB:  PubMed          Journal:  Virology        ISSN： 0042-6822            Impact factor:   3.616


  54 in total

1.  Three-dimensional structure of herpes simplex virus from cryo-electron tomography.

Authors:  Kay Grünewald; Prashant Desai; Dennis C Winkler; J Bernard Heymann; David M Belnap; Wolfgang Baumeister; Alasdair C Steven
Journal:  Science       Date:  2003-11-21       Impact factor: 47.728

2.  Analysis of fusion using a virus-free cell fusion assay.

Authors:  Marisa P McShane; Richard Longnecker
Journal:  Methods Mol Biol       Date:  2005

Review 3.  Herpesvirus entry: an update.

Authors:  Patricia G Spear; Richard Longnecker
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

4.  Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.

Authors:  Pierre Rivailler; Young-Gyu Cho; Fred Wang
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection.

Authors:  B Neuhierl; R Feederle; W Hammerschmidt; H J Delecluse
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

6.  Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein-Barr virus-induced membrane fusion.

Authors:  K M Haan; S K Lee; R Longnecker
Journal:  Virology       Date:  2001-11-10       Impact factor: 3.616

Review 7.  Simian homologues of Epstein-Barr virus.

Authors:  F Wang; P Rivailler; P Rao; Y Cho
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

8.  Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model.

Authors:  Pierre Rivailler; Hua Jiang; Young-gyu Cho; Carol Quink; Fred Wang
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

9.  Mutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusion.

Authors:  Amanda L Silva; Jasmina Omerovic; Theodore S Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

10.  Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.

Authors:  Pierre Rivailler; Angela Carville; Amitinder Kaur; Pasupuleti Rao; Carol Quink; Jeffery L Kutok; Susan Westmoreland; Sherry Klumpp; Meredith Simon; Jon C Aster; Fred Wang
Journal:  Blood       Date:  2004-05-18       Impact factor: 22.113
View more
  13 in total

1.  An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus.

Authors:  Joost Snijder; Michael S Ortego; Connor Weidle; Andrew B Stuart; Matthew D Gray; M Juliana McElrath; Marie Pancera; David Veesler; Andrew T McGuire
Journal:  Immunity       Date:  2018-04-17       Impact factor: 31.745

2.  Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.

Authors:  Anna-Katharina Wiegers; Heinrich Sticht; Thomas H Winkler; William J Britt; Michael Mach
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

3.  A Neutralizing Antibody Targeting gH Provides Potent Protection against EBV Challenge In Vivo.

Authors:  Junping Hong; Ling Zhong; Qingbing Zheng; Qian Wu; Zhenghui Zha; Dongmei Wei; Haiwen Chen; Wanlin Zhang; Shanshan Zhang; Yang Huang; Kaiyun Chen; Junyu Chen; Shaowei Li; Mu-Sheng Zeng; Yi-Xin Zeng; Ningshao Xia; Xiao Zhang; Miao Xu; Yixin Chen
Journal:  J Virol       Date:  2022-03-29       Impact factor: 6.549

4.  The Epstein-Barr virus (EBV) glycoprotein B cytoplasmic C-terminal tail domain regulates the energy requirement for EBV-induced membrane fusion.

Authors:  Jia Chen; Xianming Zhang; Theodore S Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2014-08-06       Impact factor: 5.103

5.  Epithelial cell infection by Epstein-Barr virus.

Authors:  Jia Chen; Richard Longnecker
Journal:  FEMS Microbiol Rev       Date:  2019-11-01       Impact factor: 16.408

6.  Epstein-Barr Virus gH/gL and Kaposi's Sarcoma-Associated Herpesvirus gH/gL Bind to Different Sites on EphA2 To Trigger Fusion.

Authors:  Jia Chen; Samantha Schaller; Theodore S Jardetzky; Richard Longnecker
Journal:  J Virol       Date:  2020-10-14       Impact factor: 5.103

7.  Structural basis for the recognition of human cytomegalovirus glycoprotein B by a neutralizing human antibody.

Authors:  Nadja Spindler; Uschi Diestel; Joachim D Stump; Anna-Katharina Wiegers; Thomas H Winkler; Heinrich Sticht; Michael Mach; Yves A Muller
Journal:  PLoS Pathog       Date:  2014-10-09       Impact factor: 6.823

Review 8.  Emerging Vaccine Technologies.

Authors:  Rebecca J Loomis; Philip R Johnson
Journal:  Vaccines (Basel)       Date:  2015-05-26

Review 9.  Structural and Mechanistic Insights into the Tropism of Epstein-Barr Virus.

Authors:  Britta S Möhl; Jia Chen; Karthik Sathiyamoorthy; Theodore S Jardetzky; Richard Longnecker
Journal:  Mol Cells       Date:  2016-04-06       Impact factor: 5.034

10.  Epstein-Barr virus glycoprotein gH/gL antibodies complement IgA-viral capsid antigen for diagnosis of nasopharyngeal carcinoma.

Authors:  Rui-Chen Li; Yong Du; Qiu-Yao Zeng; Lin-Quan Tang; Hua Zhang; Yan Li; Wan-Li Liu; Qian Zhong; Mu-Sheng Zeng; Xiao-Ming Huang
Journal:  Oncotarget       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.